Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H6ClN |
| Molecular Weight | 79.529 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCCl
InChI
InChIKey=VKPPFDPXZWFDFA-UHFFFAOYSA-N
InChI=1S/C2H6ClN/c3-1-2-4/h1-2,4H2
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Complexation properties and synthesis of a novel Schiff base with triphenylene nucleus. | 2010-11-15 |
|
| (E)-2,4-Dichloro-6-{1-[(2-chloro-eth-yl)imino]-eth-yl}phenol. | 2010-11-10 |
|
| Methylene blue: revisited. | 2010-10 |
|
| Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. | 2010-03-31 |
|
| 1-Methyl-4H-3,1-benzoxazine-2,4(1H)dione. | 2010-02-20 |
|
| Determination of silver(I) by differential pulse voltammetry using a glassy carbon electrode modified with synthesized N-(2-aminoethyl)-4,4'-bipyridine. | 2010 |
|
| DNA repair modulates the vulnerability of the developing brain to alkylating agents. | 2009-03-01 |
|
| The new analogues of nitrogen mustard with one, two or three 2-chloroethylamino fragments. Reactions with nucleophiles. | 2009-01-29 |
|
| Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents. | 2008-08-01 |
|
| High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. | 2007-10 |
|
| Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site. | 2007-07-01 |
|
| Synthesis and in vitro antiproliferative activity of new 1,3-(oxytetraethylenoxy)-cyclotriphosphazene derivatives. | 2007-06-29 |
|
| Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: potential for development of tumor-selective N-oxides. | 2006-11-30 |
|
| Genotoxicants target distinct molecular networks in neonatal neurons. | 2006-11 |
|
| Antihypertensive activity of chitin derivatives. | 2006-10-15 |
|
| Superparamagnetic poly(methyl methacrylate) beads for nattokinase purification from fermentation broth. | 2006-09 |
|
| Regioselective synthesis of N-beta-hydroxyethylaziridines by the ring-opening reaction of epoxides with aziridine generated in situ. | 2006-03-16 |
|
| Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives. | 2006-01-26 |
|
| Antimicrobial action of novel chitin derivative. | 2006-01 |
|
| Conjugates of phthalocyanines with oligonucleotides as reagents for sensitized or catalytic DNA modification. | 2006 |
|
| Kinetic study of DNA modification by phthalocyanine derivative of the oligonucleotide. | 2006 |
|
| Thiosugar nucleosides. Synthesis and biological activity of 1,3,4-thiadiazole, thiazoline and thiourea derivatives of 5-thio-D-glucose. | 2004 |
|
| Structure--activity relationships among novel phenoxybenzamine-related beta-chloroethylamines. | 2002-05 |
|
| Identification of new aqueous chemical degradation products of isophosphoramide mustard. | 2001-06 |
|
| Phenotypes of Drosophila homologs of human XPF and XPG to chemically-induced DNA modifications. | 2001-05-09 |
|
| A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine. | 2001-02 |
|
| [Basic stages of organizing antineoplastic chemotherapy in Russia. Role of the Russian Oncological Scientific Center named for N. N. Blokhina, Russian Academy of Medical Sciences]. | 2001 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
689-98-5
Created by
admin on Mon Mar 31 20:44:37 GMT 2025 , Edited by admin on Mon Mar 31 20:44:37 GMT 2025
|
PRIMARY | |||
|
10871
Created by
admin on Mon Mar 31 20:44:37 GMT 2025 , Edited by admin on Mon Mar 31 20:44:37 GMT 2025
|
PRIMARY | |||
|
13369
Created by
admin on Mon Mar 31 20:44:37 GMT 2025 , Edited by admin on Mon Mar 31 20:44:37 GMT 2025
|
PRIMARY | |||
|
DTXSID10218977
Created by
admin on Mon Mar 31 20:44:37 GMT 2025 , Edited by admin on Mon Mar 31 20:44:37 GMT 2025
|
PRIMARY | |||
|
P7YLY3O329
Created by
admin on Mon Mar 31 20:44:37 GMT 2025 , Edited by admin on Mon Mar 31 20:44:37 GMT 2025
|
PRIMARY |
PARENT (METABOLITE)
SUBSTANCE RECORD
